Luas Diagnostics (LD) aims to develop and market easy-to-use, rapid and accurate diagnostics tests with the aim of deploying these tests in remote settings away from centralised testing laboratories. The company has signed an exclusive distribution agreement with Chembio Diagnostics Systems (CDS) in the USA to market its Covid-19 antibody and antigen tests in the UK and Ireland. It has also signed a Memorandum of Understanding (MoU) with the University of Birmingham to develop saliva-based, rapid Covid-19 tests. LD is also working on coming up with a therapeutic drug monitoring system based on the same technology used worldwide to test people with diabetes for glucose levels in the blood. The company is developing the system so that it can be used at home, in pharmacies or GP surgery. The first product will test for Theophylline which is used to treat Chronic Obstructive Pulmonary Disease (COPD). LD will use the investment to grow its business across different verticals.
days to go:
Expired
investment:
£326,190
Rightangled is a healthcare technology company backed by NHS England & regulated by the Care Quality Commission (CQC). It began its journey as a platform that would enable the use of genetic information within the medical practice, in an accurate, streamlined, and affordable way. It gradually established itself as a healthcare provider for screening and diagnostic services. Its Heart DNA Test project, launched in 2017, is helping patients minimize their cardiac risks and enabling doctors to have a complete risk profile for their patients. The project was appreciated and received funding from NHS England. Its next project, Fitness DNA Test, tapped into the fitness and wellbeing markets. Recently, in the wake of the COVID-19 threat, the company has developed a home-based throat swab test to detect the viral infection, by testing viral load presented in its nucleic acid material within (RNA). For its efforts, Rightangled has been featured on CNN, Sky News, LBC radio, Sky News radio, and Newsweek. With the investment, the company aims to release a mobile application by the end of 2020, and develop an AI system to give instant tailored health, diet, and fitness advice to its users based on the data gathered from patient-doctor interactions and patient responses.
days to go:
Expired
investment:
£522,689
Sook is a tech-enabled enterprise that maximises the utility of empty spaces by fitting them out with a digitally-enabled canvas which anyone can put any digital content onto. It has been hailed as one of Retail Week’s 'Top 10 Global Tech Startups 2020'. Sook delivered three sites with the fourth one on Oxford Street opening soon. The company is in partnership with landlords like Grosvenor, Legal & General and Derwent London. It is also the pop-up expert for Amazon’s 'Small Business Academy'. The company has onboarded noteworthy photographer and artist David Yarrow. Sook will use the investment to bring the UK's high streets back to life in a more sustainable form.
days to go:
Expired
investment:
£843,514
Square Root (SR) aims to shake up the adult soft drinks market with its range of high-quality, fresh-pressed, small-batch sodas that contain no concentrates or artificial flavours. SR's product line includes classics, seasonal specialities, perfect serve tonics, and alcohol-free cocktails. SR asserts that unlike other craft soft drinks firms, it fully owns the soda making process from concept to bottling. The company has sold 3 million bottles to date with its products stocked in 9 Michelin star restaurants. SR has also crowdsourced a mojito recipe, secured a listing as part of the Sainsbury’s Future Brands scheme, and created collaborative-branded tonics for high-end clients like Gymkhana and Pantechnicon. The company was the winner of 3 Great Taste awards in 2019 and adjudged 'Best Drinks Producer' at the 2015 BBC Food & Farming Awards. It will use the investment to launch into the off-trade, meet increased demand, upscale its marketing strategy, and launch its drinks in cans.
days to go:
Expired
investment:
£572,128
Doisy & Dam (D&D) is a confectionery challenger brand that produces a range of dark chocolate products. It claims that its products are sold across the UK and stocked by Amazon, Sainsbury's, Holland & Barrett, Ocado, Boots, and other global markets. D&D's products are created using ethically sourced cocoa, natural ingredients and contain no traces of palm oil. The company aspires to become a contender in the UK confectionery market that was worth £3.9 billion in April 2021. It further points out that people are aware of the health and the sustainability credentials of the products they buy. It intends to target this sentiment and become an established brand. The company states it has grown its sales to over £1 million and aspires to become the best dark chocolate confectioner in the UK. D&D state they will use the investment for marketing, expanding its product range, and growing its export business.
days to go:
Expired
investment:
£515,735
KLORIS manufactures and sells premium Cannabidiol (CBD) wellness and beauty products. The company follows a Direct-To-Consumer (DTC) model and has garnered over 1,400 loyalty club members achieving a conversion rate of over 3.4%. KLORIS asserts that this has allowed the company to build brand loyalty and respond quickly to customer needs while maintaining high gross margins. The company has procured over 20 Stock Keeping Units (SKU), is listed in leading retailers like Boots, Selfridges, Amazon Prime, Mankind, and Lookfantastic, and has signed spa treatment partnerships with BVLGARI Spa, Cloud Twelve, and others. KLORIS has earned over 120 reviews with an 'Excellent' Trustpilot rating and was shortlisted for 'Best Wellness and Self-Care Brand' in the Sunday Times STYLE Beauty Awards 2021. The company will use 40% of the investment for PR and marketing, 35% for hiring key personnel, 16% for New Product Development (NPD), and 9% for hosting events.
days to go:
Expired
investment:
£334,396
Power Transition (PT) is a specialist cloud-based software & hardware platform that enables every participant in the energy sector to dynamically track, optimise and balance their energy in real-time and at any scale, from micro-grids to national grids. It is currently focusing on the UK residential & commercial market that consists of 1.25 million meter readings daily, focussing on £1.5 billion of customers’ funds annually, and ensuring steady and reliable management of interconnections throughout the UK. In 2018, the company raised seed funding, matched by Innovate UK, which in turn is being used, to develop and deploy its technology in 47 homes in Corby. The company is implementing its PT integrated microgrid as a 'Service Platform' in houses in Corby using its Distributed Ledger Technology (DLT) Network. With the investment, the company plans to roll out its platform beyond the microgrid use case and is talking to commercial estates, local authorities, Distributed Network Operators (DNO), energy aggregators, and producers.
days to go:
Expired
investment:
£266,530
Propelair is a company that has developed the world’s lowest water-flush toilet system. The toilet uses air to propel 1.5 litres of water per flush, saving water when compared to 6-9 litres per flush for conventional toilets. The company has installed nearly 4,000 units in the UK and South Africa. They were awarded the prestigious Horizon2020 grant in 2017 to develop new innovations. It has also been featured in publications such as The Daily Telegraph, London Evening Standard, and The Times. The company will use the investment as working capital and stock acquisition funds to enable growth, in the UK and South Africa and launch into other water-stressed markets like the Middle East, Australia, Hong Kong, and Singapore, and introduce its 'Smart Connected Toilet' to the market.
days to go:
Expired
investment:
£1,236,245
Symmetrical Power has developed an innovative solution that addresses the issue of energy wastage. After identifying the inefficiency of the 3 Phase Electrical Distribution Boards, Symmetrical Power is creating the ‘Intelligent Distribution Board’ (ID Board). It aims to prevent the challenge of peak demand whilst saving on energy bills. The working model of the product also received positive feedback from electrical specialists. Additionally, Symmetrical Power was also a Shell Springboard regional finalist (2018) for its new low-carbon ideas. With the proceeds, the company will complete design & begin distribution in Europe and to position itself as the go-to Distribution Board provider.
days to go:
Expired
investment:
£233,600
SMARTR Health Limited, also called Celsium, is a medical technology company. It has developed the world’s first medical-grade device that continuously measures core temperature, both accurately and non-invasively, through a combination of a wearable sensor and a smart platform. Intended for use in the formal healthcare sector, as well as at home, it has been classified as a CE Class 2A medical device in the EU and as an FDA 510K medical device in the US. In a clinical study, conducted in collaboration with Boston Children’s Hospital and Cleveland Clinic, the company's product showed promising results 10-20 times more accurate than current devices. Celsium has experienced a surge in demand due to Covid-19, where fever is a key symptom. This, the company argues, is a perfect time to accelerate its business plan.
days to go:
Expired
investment:
Withheld
